Thomas Reiser/X
Jun 1, 2025, 06:21
Thomas Reiser Shares ISTH’s New eLearning Module on PNH and ITP
Thomas Reiser, Executive Director of International Society on Thrombosis and Haemostasis, shared a post on X.
“ Explore the ISTH eLearning module. Navigating New Horizons in PNH and ITP – Perspectives for the Community. Developed in conjunction with
MedscapeOnc”
Understanding rare blood disorders like PNH and ITP is critical for improving patient outcomes. The latest ISTH eLearning module, developed with MedscapeOnc, offers valuable insights into evolving therapies.
Learn more here.
Stay informed with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis